Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation.
Hagihara M, Yamashita M, Ariyoshi T, Eguchi S, Minemura A, Miura D, Higashi S, Oka K, Nonogaki T, Mori T, Iwasaki K, Hirai J, Shibata Y, Umemura T, Kato H, Asai N, Yamagishi Y, Ota A, Takahashi M, Mikamo H. Hagihara M, et al. Among authors: shibata y. Cell Rep. 2022 Dec 13;41(11):111755. doi: 10.1016/j.celrep.2022.111755. Cell Rep. 2022. PMID: 36516771 Free article.
Mycobiome and Mycobiome-Associated Diseases.
Hagihara M, Kato H, Shibata Y, Umemura T, Ariyoshi T, Hirai J, Asai N, Mori N, Mikamo H. Hagihara M, et al. Among authors: shibata y. Med Mycol J. 2023;64(3):55-62. doi: 10.3314/mmj.23-002. Med Mycol J. 2023. PMID: 37648499 Free article. Review.
Lung cancer progression alters lung and gut microbiomes and lipid metabolism.
Hagihara M, Kato H, Yamashita M, Shibata Y, Umemura T, Mori T, Hirai J, Asai N, Mori N, Mikamo H. Hagihara M, et al. Among authors: shibata y. Heliyon. 2023 Dec 9;10(1):e23509. doi: 10.1016/j.heliyon.2023.e23509. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38169741 Free PMC article.
Epidemiological study of respiratory syncytial virus infection in adults during the pandemic of COVID-19.
Asai N, Shibata Y, Yamada A, Ohashi W, Takayama M, Kawamoto Y, Miyazaki N, Sakanashi D, Ohno T, Nakamura A, Koita I, Suematsu H, Chida S, Ohta T, Kato H, Hagihara M, Hirai J, Mori N, Mikamo H. Asai N, et al. Among authors: shibata y. J Infect Chemother. 2024 May 21:S1341-321X(24)00130-2. doi: 10.1016/j.jiac.2024.05.004. Online ahead of print. J Infect Chemother. 2024. PMID: 38782237
Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery.
Soga Y, Iida O, Seki SI, Kawasaki D, Anzai H, Ando H, Nakama T, Shinozaki N, Kozuki A, Ishihara M, Urasawa K, Toi S, Tsujita H, Tobita K, Ogata K, Horie K, Hayakawa N, Mori S, Fujihara M, Ohki T, Yuba K, Mano T, Ando K, Nakamura M; TCD-17187 Japan Investigators. Soga Y, et al. Cardiovasc Intervent Radiol. 2024 May 30. doi: 10.1007/s00270-024-03747-4. Online ahead of print. Cardiovasc Intervent Radiol. 2024. PMID: 38816504
Simple prediction tools for disease progression in unvaccinated patients with mild/moderate COVID-19 aged under 65 years: Simplified DOATS and DOAT scores.
Shibata Y, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Rikimaru M, Kawamata T, Togawa R, Sato Y, Saito J, Kanazawa K, Iseki K; Doctors in Fukushima and Yamagata against COVID-19. Shibata Y, et al. Respir Investig. 2024 May 22;62(4):681-684. doi: 10.1016/j.resinv.2024.05.006. Online ahead of print. Respir Investig. 2024. PMID: 38781788
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies.
Beebe KD, Eisner JR, Guo J, Shibata Y, Davison JM, Uronis J, Farhangfar C, Farhangfar F, Mooney J, Milburn MV, White RL, Amin A, Milla ME, Foureau DM. Beebe KD, et al. Among authors: shibata y. J Immunol. 2024 May 20:ji2300736. doi: 10.4049/jimmunol.2300736. Online ahead of print. J Immunol. 2024. PMID: 38767437
2,720 results